BITOSSI, ALICE
 Distribuzione geografica
Continente #
EU - Europa 383
NA - Nord America 347
AS - Asia 118
Totale 848
Nazione #
US - Stati Uniti d'America 341
RU - Federazione Russa 100
IT - Italia 85
PL - Polonia 76
IE - Irlanda 43
SE - Svezia 35
HK - Hong Kong 27
IN - India 25
CH - Svizzera 24
CN - Cina 24
JO - Giordania 21
SG - Singapore 11
CA - Canada 6
DE - Germania 6
VN - Vietnam 6
GB - Regno Unito 5
FI - Finlandia 3
BE - Belgio 2
ES - Italia 2
KR - Corea 2
AT - Austria 1
JP - Giappone 1
NL - Olanda 1
TR - Turchia 1
Totale 848
Città #
Warsaw 76
Fairfield 50
Dublin 43
Chandler 40
Woodbridge 28
Bern 24
Ashburn 23
Altamura 20
Lawrence 20
Moscow 17
Cambridge 16
Florence 16
Hong Kong 16
Houston 13
Shanghai 12
Princeton 11
Seattle 11
Mumbai 10
Boston 9
Wilmington 9
Boardman 8
New York 8
Buffalo 7
Singapore 7
Dong Ket 6
Ann Arbor 5
Bengaluru 5
Bologna 4
Cagliari 4
Castelfranco di Sotto 4
Medford 4
Altidona 3
Chennai 3
Falls Church 3
Islington 3
Kent 3
Norwalk 3
San Diego 3
Somerville 3
Strada in Chianti 3
Taizhou 3
Toronto 3
Vaddangi 3
Washington 3
Agliana 2
Brussels 2
Desio 2
Gurugram 2
Lappeenranta 2
Leawood 2
Montréal 2
Rome 2
Sorbolo 2
Stezzano 2
West Jordan 2
Andover 1
Beijing 1
Castelliri 1
Helsinki 1
Hillsboro 1
Irkutsk 1
Jacksonville 1
Kochi 1
Los Angeles 1
Melilla 1
New Delhi 1
Norwich 1
Padova 1
Redwood City 1
Reggio Emilia 1
Santa Clara 1
Seoul 1
Stoney Creek 1
Telgate 1
Terranuova Bracciolini 1
Valladolid 1
Vienna 1
Wernigerode 1
Wuhan 1
Totale 611
Nome #
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 144
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 115
Morpho-Functional Evaluation of Full-Thickness Macular Holes by the Integration of Optical Coherence Tomography Angiography and Microperimetry 91
I farmaci biologici 62
Long-term Retention Rates of Adalimumab and Infliximab in Non-Infectious Intermediate, Posterior, and Panuveitis 60
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 58
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 56
Evaluation of intraoperative slow-release dexamethasone implant combined with idiopathic epiretinal membrane removal 53
Efficacy of adalimumab for the treatment of noninfectious uveitis in a real world setting 49
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy—a Systematic Review 46
Non-anti TNFα biologic agents for noninfectious uveitis associated with systemic inflammatory diseases: a systematic review 45
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 45
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 43
Totale 867
Categoria #
all - tutte 3.312
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.312


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 3 6 4 4 7 7 6 9 16
2020/2021166 9 15 2 14 36 13 25 7 15 13 3 14
2021/202266 0 1 4 2 0 13 0 4 3 4 10 25
2022/2023265 19 63 15 4 7 34 25 14 41 5 12 26
2023/2024173 4 10 17 10 13 21 4 33 18 19 7 17
2024/2025124 31 78 15 0 0 0 0 0 0 0 0 0
Totale 867